Biocept Announces One-for-Thirty Reverse Stock Split
As a result of the reverse stock split, each 30 pre-split shares of common stock outstanding were automatically combined and converted into one issued and outstanding share of common stock. No fractional shares of common stock were issued to any stockholders in connection with the reverse stock split. Holders of record will receive a cash payment in lieu of fractional shares.
Stockholders of record will receive information regarding their share ownership following the reverse stock split from the Company’s transfer agent,
For additional information regarding the reverse stock split, please refer to Biocept’s Current Report on Form 8-K, filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230517005283/en/
Investor and Media Contact: